Quantum Genomics SA is a biopharmaceutical company, which develops new medication class for cardiovascular disease, such as high blood pressure and heart failure. It engages in research programs, that are based on the brain inhibition mechanism of aminopeptidase. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$3.40    OTCQX
As of 07/01/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Index country:  France
Country of incorporation:  
IPO date:  12/23/2021
Outstanding shares:  34,619,981
Average volume:  0
Market cap:   $117,707,935
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy